Eric Venker
Board Member
Arbutus Biopharma Corp (ABUS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Immunovant, Inc. (IMVT) | Chief Executive Officer | $636,618 | $20,158,767 |
| 2025 | Roivant Sciences Ltd. (ROIV) | President and Immunovant CEO | $75,000 | $24,400,210 |
| 2024 | Roivant Sciences Ltd. (ROIV) | President and Immunovant CEO | $600,208 | $11,807,422 |
| 2023 | Roivant Sciences Ltd. (ROIV) | President and Immunovant CEO | $570,000 | $632,420 |
| 2022 | Roivant Sciences Ltd. (ROIV) | President and Immunovant CEO | $569,806 | $48,487,966 |
| 2021 | Roivant Sciences Ltd. (ROIV) | M.D., Pharm.D. President and Chief Operating Officer | $620,000 | $24,308,300 |
| 2020 | Roivant Sciences Ltd. (ROIV) | M.D., Pharm.D. President and Chief Operating Officer | $275,000 | $10,296,550 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.